Ultralife Receivables

The latest receivables for ULBI is $34M as of March 2026. That compares with $36M in the prior-year period — down 4.5% year over year. Investors often review this figure alongside Ultralife's historical trend and sector peers before judging valuation or financial health.

Over the past year, ULBI's receivables moved from $36M to $34M — a 4.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ultralife's operating scale or balance-sheet position.

A receivables figure of $34M for ULBI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ULBI's receivables ($34M), review year-over-year change from $36M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Ultralife's receivables against similar Industrials names. You can also browse sector and industry screens on Stockcircle for a broader set of Industrials companies and their key multiples and fundamentals.